Retina Eye Center

09/11/2025

Patients with AMD or DME often face major challenges like anxiety, travel issues, and treatment fatigue from frequent injections. Better support and communication can lead to better outcomes. Learn more: https://brnw.ch/21wVGyF

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

09/09/2025

“Wonderful experience at this office!” We’re grateful for kind words like these about Dr. Dhaliwal and our team. Providing expert, professional care is what we’re here for.

09/04/2025

TINU syndrome is a rare condition that affects both the kidneys and eyes, most often in teens and young adults. Because symptoms can appear at different times and may be subtle, early diagnosis requires careful coordination between doctors. Learn how a multidisciplinary approach made the difference in a recent case by reading the full article: https://brnw.ch/21wVtY0

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

09/01/2025

In observance of Labor Day, our offices will be closed as we honor the hard work and dedication of our team. We’ll reopen with normal hours tomorrow. Wishing everyone a safe and restful holiday.

08/28/2025

New research highlights potential biomarkers that could help detect diabetic retinopathy earlier than ever before. The study found changes in retinal blood vessel shape and branching patterns in patients with DR, clues that could lead to earlier diagnosis and treatment, possibly even before symptoms appear. Learn more: https://brnw.ch/21wVhLS

A study reveals significant retinal vessel changes in diabetic retinopathy, highlighting the need for early detection methods to prevent vision loss.

08/26/2025

The Retina Eye Center is proud to be part of Retina Consultants of America, a nationwide network of top retinal care and research practices. Together, we are raising the bar for patient care and shaping the future of retinal health.

08/21/2025

Our Aiken location delivers specialized retinal care to patients across the Central Savannah River Area, including Clearwater, Edgefield, Graniteville, and more. From macular degeneration to diabetic retinopathy, expert care is just a call away. Call (803) 644-7171 to schedule. Learn more: https://brnw.ch/21wV6oE

08/19/2025

PYC Therapeutics is moving forward with a registrational trial for VP-001, a potential treatment for retinitis pigmentosa type 11, after receiving positive feedback from the FDA. Early studies have shown improvements in vision and retinal sensitivity, and the upcoming trial could bring this promising therapy one step closer to patients. Learn more: https://brnw.ch/21wV2Da

PYC Therapeutics advances VP-001 for retinitis pigmentosa, gaining FDA insights for its upcoming registrational trial.

08/14/2025

The Retina Eye Center is the longest-standing vitreoretinal practice in the Central Savannah River Area, trusted for over 30 years. Patients from across state lines turn to us for expert care, advanced technology, and compassionate support no matter how complex the case. Learn more about us: https://brnw.ch/21wUUEW

08/12/2025

Nanoscope Therapeutics has begun the rolling submission of its BLA to the FDA for MCO-010, a groundbreaking gene-agnostic therapy for retinitis pigmentosa. If approved, it could become the first treatment to restore vision in legally blind RP patients, offering new hope regardless of genetic cause. Full submission is expected by early 2026. Learn more: https://brnw.ch/21wURGZ

At the 2025 International SPECTRALIS Symposium—And Beyond (ISS), Chauhan discussed how two-photon microscopy enables precise, non-invasive monitoring of retinal ganglion cell function in living subjects.

08/07/2025

Early trials show that PER-001 may help restore vision in patients with glaucoma and diabetic retinopathy. This slow-release implant, given every six months, improves blood flow and protects retinal cells, potentially reversing vision loss. It could be the first treatment to actually change the course of these diseases. Learn more: https://brnw.ch/21wUKH5

Both 6-month trials were randomized, controlled studies that evaluated PER-001 delivered in a slow-release, dissolvable implant injected intravitreally every 6 months.

08/05/2025

Seeing more floaters or flashes than usual? It might be more than normal aging and could be vitreomacular traction, a condition that affects your central vision. Learn the signs and when to seek care in our latest blog: https://brnw.ch/21wUGVx